Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Acta Neuropathologica

• Publication date

  2004-01-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00401-003-0801-3PMID 14712399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parkinsonism in HIV dementia

  2002cited by this paper
• Macaque animal model for HIV-induced neurological disease

  2002cited by this paper
• Involvement of dopamine in the progression of AIDS Dementia Complex

  2002cited by this paper
• Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs

  2001influential reference
• Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV.

  2000cited by this paper
• Early Activation and Proliferation of T Cells in Simian Immunodeficiency Virus-Infected Rhesus Monkeys

  2000cited by this paper
• Neuropathology and general autopsy findings in AIDS during the last 15 years

  2000cited by this paper
• Dopamine activates HIV in chronically infected T lymphoblasts

  2000cited by this paper
• Homozygosity for a conserved Mhc class II DQ-DRB haplotype is associated with rapid disease progression in simian immunodeficiency virus-infected macaques: results from a prospective study.

  2000cited by this paper
• Effects of Selegiline in a retroviral rat model for neurodegenerative disease.

  1999cited by this paper
• Upregulation of microglia in drug users with and without pre‐symptomatic HIV infection

  1999cited by this paper
• Morphological correlates of neurological dysfunction in macaques infected with neurovirulent simian immunodeficiency virus

  1999cited by this paper
• Parkinsonism with HIV infection

  1998cited by this paper
• Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS

  1998cited by this paper
• Cocaine abuse: hard knocks for the dopamine hypothesis?

  1998cited by this paper
• Distribution of Brain HIV Load in AIDS

  1998cited by this paper
• Protective Role of the Virus-Specific Immune Response for Development of Severe Neurologic Signs in Simian Immunodeficiency Virus-Infected Macaques

  1998cited by this paper
• Neuropathogenesis of acquired immunodeficiency syndrome dementia

  1997cited by this paper
• HIV dementia and the basal ganglia.

  1997cited by this paper
• Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro.

  1997cited by this paper
• HIV‐associated brain pathology in the United Kingdom: an epidemiological study

  1997cited by this paper
• Nature and sequence of simian immunodeficiency virus-induced central nervous system lesions: a kinetic study

  1996influential reference
• Neuropathology of human immunodeficiency virus infection at different disease stages.

  1996influential reference
• Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

  1996cited by this paper
• HIV-1 neuropathogenesis and abused drugs: current reviews, problems, and solutions.

  1996cited by this paper
• Modulation of gene expression rather than monoamine oxidase inhibition

  1996cited by this paper
• Chicken Ovalbumin Upstream Promoter Transcription Factor, a Transcriptional Activator of HIV-1 Gene Expression in Human Brain Cells*

  1996cited by this paper
• Hiv-1 Neuropathogenesis and Abused Drugs

  1996cited by this paper
• Comparative sequence analysis of cytokine genes from human and nonhuman primates.

  1995cited by this paper
• Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system.

  1995cited by this paper
• The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases.

  1995cited by this paper
• NMDA Antagonists as Neurotherapeutic Drugs, Psychotogens, Neurotoxins, and Research Tools for Studying Schizophrenia

  1995cited by this paper
• D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines.

  1994cited by this paper
• A Review of Neuronal Damage in Human Immunodeficiency Virus Infection: Its Assessment, Possible Mechanism and Relationship to Dementia

  1993cited by this paper
• Cocaine modulation in vitro of tumor necrosis factor production by macrophages from retrovirally infected mice.

  1993cited by this paper
• Neuropathologic analysis of postmortal brain samples of HIV-seropositive and -seronegative i.v. drug addicts.

  1993cited by this paper
• Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds

  1993cited by this paper
• Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus

  1993cited by this paper
• Cortical dendritic pathology in human immunodeficiency virus encephalitis.

  1992influential reference
• Neocortical damage during HIV infection

  1991influential reference
• Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications.

  1991cited by this paper
• HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology

  1991cited by this paper
• Oxidative stress: a role in the pathogenesis of Parkinson's disease.

  1990cited by this paper
• Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

  1990cited by this paper
• Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

  1990cited by this paper
• Spongiform encephalopathy in AIDS dementia complex: report of five cases.

  1989influential reference
• Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

  1988cited by this paper
• A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis)

  1984cited by this paper
• Neuropathologic aspects of drug dependency (narcotic addiction).

  1972cited by this paper

• Dopamine-driven increase in IL-1β in myeloid cells is mediated by differential dopamine receptor expression and exacerbated by HIV

  2025cites this paper
• Serotonergic and Dopaminergic Function in Neuropsychiatrically Asymptomatic People With HIV on Antiretroviral Therapy

  2025cites this paper
• Alpha-synuclein and RNA viruses: Exploring the neuronal nexus.

  2024cites this paper
• Dopamine-driven Increase in IL-1β in Myeloid Cells is Mediated by Differential Dopamine Receptor Expression and Exacerbated by HIV

  2024cites this paper
• Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.

  2023cites this paper
• Virus infection participates in the occurrence and development of human diseases through monoamine oxidase

  2023cites this paper
• Deprenyl reduces inflammation during acute SIV infection

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation

  2021cites this paper
• HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System

  2020influential citation
• HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System

  2020cites this paper
• Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease

  2019cites this paper
• HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

  2019cites this paper
• Dopaminergic impact of cART and anti-depressants on HIV Neuropathogenesis in older adults.

  2019cites this paper
• HIV infection alters energy metabolism in the brain: contributions to HIV-associated neurocognitive disorders

  2019cites this paper
• The role of catecholamines in HIV neuropathogenesis.

  2019influential citation
• The Impact of Substance Abuse on HIV-Mediated Neuropathogenesis in the Current ART Era.

  2019cites this paper
• Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

  2019influential citation
• The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

  2018cites this paper
• Role of microglia in methamphetamine-induced neurotoxicity.

  2017cites this paper
• HIV, Tat and dopamine transmission.

  2017cites this paper
• HIV-1 proteins, Tat and gp120, target the developing dopamine system.

  2015cites this paper
• Dopamine modulates hemocyte phagocytosis via a D1-like receptor in the rice stem borer, Chilo suppressalis

  2015cites this paper
• Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis

  2015cites this paper
• A novel role for and potential therapeutic targeting of heme oxygenase-1 in HIV neuropathogenesis

  2015cites this paper
• Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages

  2014cites this paper
• Drugs of Abuse and NeuroAIDS: Opiates

  2014cites this paper
• Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

  2014cites this paper
• Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence

  2014cites this paper
• CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

  2013cites this paper
• National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia

  2013cites this paper
• Drug Induced Increases in CNS Dopamine Alter Monocyte, Macrophage and T Cell Functions: Implications for HAND

  2013cites this paper
• Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance

  2012cites this paper
• Opiate Drug Use and the Pathophysiology of NeuroAIDS

  2012cites this paper
• Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia

  2011influential citation
• Cannabinoid rescue of striatal progenitor cells in chronic Borna Disease viral encephalitis in rats

  2011cites this paper
• Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses

  2010cites this paper
• Hyperdopaminergic tone in HIV‐1 protein treated rats and cocaine sensitization

  2010cites this paper
• Selegiline and oxidative stress in HIV-associated cognitive impairment

  2009cites this paper
• Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.

  2009influential citation
• Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage

  2009cites this paper
• Die HIV-assoziierte Demenz und ihre Vorstufen

  2008cites this paper
• Contributions of non-human primates to neuroscience research.

  2008cites this paper
• Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

  2008cites this paper
• The effects of illicit drugs on the HIV infected brain.

  2008cites this paper
• Memantine Upregulates BDNF and Prevents Dopamine Deficits in SIV-Infected Macaques: A Novel Pharmacological Action of Memantine

  2008cites this paper
• HIV Dementia: A Neurodegenerative Disorder with Viral Etiology

  2007cites this paper
• Neuropharmacology of HIV/AIDS.

  2007cites this paper
• Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

  2007cites this paper
• HIV‐1 neuropathogenesis: glial mechanisms revealed through substance abuse

  2007cites this paper
• Neuroimmunity and the Blood–Brain Barrier: Molecular Regulation of Leukocyte Transmigration and Viral Entry into the Nervous System with a Focus on NeuroAIDS

  2006cites this paper
• Neonatal intrahippocampal gp 120 injection : The role of dopaminergic alterations in prepulse inhibition in adult rats

  2006cites this paper
• Neonatal Intrahippocampal Glycoprotein 120 Injection: The Role of Dopaminergic Alterations in Prepulse Inhibition in Adult Rats

  2006cites this paper
• Early impairment in dopaminergic neurotransmission in brains of SIV‐infected rhesus monkeys due to microglia activation

  2005cites this paper
• Neuropsychopathology in the SIV/macaque model of AIDS.

  2005cites this paper
• Deprenyl enhances the striatal neuronal damage produced by quinolinic acid.

  2005cites this paper
• Psychotropic viruses.

  2004cites this paper